JPH0262531B2 - - Google Patents

Info

Publication number
JPH0262531B2
JPH0262531B2 JP60245794A JP24579485A JPH0262531B2 JP H0262531 B2 JPH0262531 B2 JP H0262531B2 JP 60245794 A JP60245794 A JP 60245794A JP 24579485 A JP24579485 A JP 24579485A JP H0262531 B2 JPH0262531 B2 JP H0262531B2
Authority
JP
Japan
Prior art keywords
serum
cholesterol
total cholesterol
administration
nitsusui
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60245794A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62106019A (ja
Inventor
Keiko Takahashi
Toshio Wakabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP60245794A priority Critical patent/JPS62106019A/ja
Priority to US06/925,239 priority patent/US4794115A/en
Priority to EP86402442A priority patent/EP0228314A3/en
Publication of JPS62106019A publication Critical patent/JPS62106019A/ja
Publication of JPH0262531B2 publication Critical patent/JPH0262531B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP60245794A 1985-11-01 1985-11-01 抗高脂血症剤 Granted JPS62106019A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP60245794A JPS62106019A (ja) 1985-11-01 1985-11-01 抗高脂血症剤
US06/925,239 US4794115A (en) 1985-11-01 1986-10-31 Method of treating hyperlipemia
EP86402442A EP0228314A3 (en) 1985-11-01 1986-10-31 Use of ethanol/amine derivatives in treating or preventing hyperlipemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60245794A JPS62106019A (ja) 1985-11-01 1985-11-01 抗高脂血症剤

Publications (2)

Publication Number Publication Date
JPS62106019A JPS62106019A (ja) 1987-05-16
JPH0262531B2 true JPH0262531B2 (https=) 1990-12-26

Family

ID=17138927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60245794A Granted JPS62106019A (ja) 1985-11-01 1985-11-01 抗高脂血症剤

Country Status (3)

Country Link
US (1) US4794115A (https=)
EP (1) EP0228314A3 (https=)
JP (1) JPS62106019A (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
WO2011028689A1 (en) 2009-09-01 2011-03-10 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH513166A (it) * 1968-07-31 1971-09-30 Siphar Sa Procedimento per la fabbricazione del p-chlorofenossiisobutirrato di 2-nicotinoilossietilamina
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
JPS60197642A (ja) * 1984-03-21 1985-10-07 Terumo Corp エタノ−ルアミン誘導体およびこれを有効成分として含有する血小板凝集抑制剤

Also Published As

Publication number Publication date
JPS62106019A (ja) 1987-05-16
EP0228314A3 (en) 1990-03-28
US4794115A (en) 1988-12-27
EP0228314A2 (en) 1987-07-08

Similar Documents

Publication Publication Date Title
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
JPH0262531B2 (https=)
US4325974A (en) β, γ-Dihydropolyprenyl alcohol and hypotensive pharmaceutical composition containing same
US5455268A (en) Esculetin derivatives and pharmaceutical composition
EP0054732B1 (en) Conjugated polyprenylcarboxylic acids and their derivatives as well as pharmaceutical preparations containing these compounds
US3892769A (en) Acetaminophen esters of aryl salicylic acids
US5321045A (en) Method and composition for the treatment of imflammatory conditions using thiosulphinic acid derivatives
JPS597163A (ja) 抗動脈硬化剤
JPS58206524A (ja) 抗腫瘍剤
EP0232089A2 (en) Quinone amides, their production and use
FR2553663A1 (fr) Derives du 1,2-dithiolanne, leur preparation et leur utilisation comme medicaments
JPH01132530A (ja) コレステロール代謝障害治療剤
JPH0514708B2 (https=)
US4199587A (en) Method of treating hypertension with polyprenyl alcohol ester
CH644842A5 (de) Fettsaeure-amide ihre herstellung und ihre verwendung als pharmazeutika.
JPH01290624A (ja) ５，６―セコ―ステロール誘導体血清脂質低下剤
JPH0623102B2 (ja) 脂質低下剤
DE68906854T2 (de) Dihydropyridinderivate.
DE60208554T2 (de) Neue aliphatische verbindung, syntheseverfahren und anwendungsverfahren
EP0588799B1 (de) Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
JPS637558B2 (https=)
EP0653206A1 (en) Anti-hiv agent
DE3308004A1 (de) Verwendung von dibenzocycloheptenyliden-verbindungen zur modulation der immunreaktion
JPS62106080A (ja) エタノ−ルアミン誘導体およびこれを含有する抗高脂血症剤
DE2834911C2 (de) Antihypertonikum